Nanalysis Scientific financials at a glance

+ Portfolio

The revenue of Nanalysis Scientific is reported as 0.02847 billion Dollars in the fiscal year 2023. The earnings were -0.13 Dollars per share in 2023, which was 400 lower than 2021. And about -0.0006 billion Dollars are reported as free cash flow in the financials of Nanalysis Scientific 2023. No dividends were paid to the shareholders of the Nanalysis Scientific stock TSXV:NSCI in the financial year 2023.

C$24.82M

Revenue

C$-0.10

Earnings Per Share

44.88%

Gross Margin %

C$0.00M

Free Cash Flow

Revenue

24.82

Earnings Per Share

-0.10

Gross Margin %

44.88

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021
Rev.	Revenue	N/A	C$24.82M	C$16.04M
GM %	Gross Margin %	15.98%	44.88%	63.83%
OM	Operating Margin	-60.85%	-40.51%	-7.42%
EPS	Earnings Per Share	C$-0.17	C$-0.10	C$-0.02
Div.	Dividends	N/A	C$0.00	C$0.00
PR %	Payout Ratio %	0	0	0
Sha.	Shares	N/AM	94.45M	77.17M
OCF	Operating Cash Flow	N/A	C$0.00M	C$-1.20M
FCF	Free Cash Flow	N/A	C$0.00M	C$-1.80M
FCFS	Free Cash Flow Per Share	C$-0.19	C$-0.17	C$-0.06

Nanalysis Scientific financials at a glance

Financials

Discover